Amundi Asset Management US’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$211M Buy
1,644,311
+120,831
+8% +$14.9M 0.16% 144
2020
Q4
$182M Buy
1,523,480
+197,851
+15% +$24.1M 0.15% 154
2020
Q3
$152M Buy
1,325,629
+35,309
+3% +$4.17M 0.16% 134
2020
Q2
$147M Sell
1,290,320
-48,626
-4% -$5.16M 0.17% 119
2020
Q1
$48.6M Sell
1,338,946
-144,941
-10% -$15M 0.08% 227
2019
Q4
$158M Buy
1,483,887
+131,268
+10% +$13.7M 0.19% 124
2019
Q3
$145M Buy
1,352,619
+5,354
+0.4% +$550K 0.22% 110
2019
Q2
$950M Sell
1,347,265
-14,939
-1% -$1.44M 0.78% 28
2019
Q1
$122M Buy
1,362,204
+1,163,946
+587% +$101M 0.17% 127
2018
Q4
$16.5M Sell
198,258
-6,627
-3% -$621K 0.02% 529
2018
Q3
$22.1M Buy
204,885
+21,071
+11% +$2.31M 0.03% 508
2018
Q2
$20.2M Buy
183,814
+34,480
+23% +$3.59M 0.03% 515
2018
Q1
$15M Buy
149,334
+24,778
+20% +$2.54M 0.02% 576
2017
Q4
$12.3M Buy
+124,556
New +$11.8M 0.02% 621
2016
Q3
Sell
-184,754
Closed -$15M 548
2016
Q2
$15M Buy
184,754
+61,592
+50% +$4.69M 0.05% 237
2016
Q1
$8.8M Sell
123,162
-97,394
-44% -$6.53M 0.03% 313
2015
Q4
$15.7M Buy
220,556
+3,609
+2% +$243K 0.06% 251
2015
Q3
$13.3M Sell
216,947
-314,572
-59% -$22M 0.05% 274
2015
Q2
$38.5M Sell
531,519
-30,894
-5% -$2.28M 0.14% 171
2015
Q1
$43.2M Buy
+562,413
New +$40.3M 0.15% 168

Other funds holding DGX

Amundi Asset Management US's DGX Position: Q1 2021 in Review

Amundi Asset Management US increased its Quest Diagnostics (DGX) stake by 7.9% in Q1 2021, buying an estimated $14.9M and bringing the position to 1,644,311 shares worth $211M. The position accounts for 0.16% of the portfolio, ranked #144.

Amundi Asset Management US first reported a position in DGX in Q1 2015 and has held it in 20 quarters since. The position peaked at $950M in Q2 2019. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Amundi Asset Management US held 1,644,311 shares of Quest Diagnostics worth $211M as of Q1 2021.
  • Amundi Asset Management US bought 120,831 Quest Diagnostics shares in Q1 2021, an estimated $14.9M.
  • Quest Diagnostics made up 0.16% of Amundi Asset Management US's portfolio in Q1 2021, its #144 holding.
  • Amundi Asset Management US first reported a position in Quest Diagnostics in Q1 2015 and has held it in 20 quarters since.
  • Amundi Asset Management US's Quest Diagnostics position peaked at $950M in Q2 2019.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.